Ten analysts recently shared bullish-to-bearish takes on Elevance Health over the last three months, leaning heavily bullish.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $484.4, a high estimate of $522.00, and a low estimate of $434.00. A negative shift in sentiment ...

Affiliates of UnitedHealth and other large insurers employed about 6.8% of the physicians who billed Medicare.

UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across the sector.

ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.

Health insurance companies have pledged to improve prior authorization with 6 key reforms, according to the HHS.

Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during ...

Analysts have given Elevance Health a consensus rating of “Moderate Buy,” with twelve of sixteen recommending purchase and ...

Financials make up half of the 38 S&P 500 companies slated to report quarterly results this week. The week’s big economic news will be the consumer price index for June.

Wellpoint, a leading provider of managed care services, recently announced that Alicia Kenyon, MSW, has been named president ...

The Trump Administration is bringing prior authorizations (PAs), the mandatory preapproval before insurance covers health ...

Lobbyists in Connecticut have a bad reputation, and it may get worse with the recent report from the Office of State Ethics that spending on lobbyists exceeded $28 million in the first quarter of this ...